Msci Inc vs GeneDx Holdings Corp — how do they compare? Msci Inc trades at $562.51 (market cap $45.51B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Msci Inc is far larger — about 25.3× GeneDx Holdings Corp's market cap, and Msci Inc pays a 1.31% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| MSCI | WGS | |
|---|---|---|
Market Cap | $45.51B | $1.80B |
Sector | Financials | Technology |
52-Week High | $643.83 | $167.51 |
52-Week Low | $511.84 | $34.51 |
Enterprise Value | $51.67B | $1.80B |
Dividend Yield | 1.31% | — |
Trailing returns across standard periods
Latest headlines on both assets
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →